Banner
Structure

D-Thyroxine monosodium salt

CAS
137-53-1
Catalog Number
ACM137531
Category
Main Products
Molecular Weight
798.85
Molecular Formula
C15H10I4NNaO4

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
sodium;(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
Appearance
White solid

Analysis for Binding of Thyroxine Enantiomers to Human Serum Albumin

Tomoko Kimura, et al. Pharmaceutical research, 2005, 22, 667-675.

Thyroxine (T4) is a thyroid hormone that binds strongly to plasma proteins such as albumin, thyroxine-binding globulin, and transthyretin. High-performance frontal analysis (HPFA) methods can be used to qualitatively and enantioselectively characterize the binding properties between thyroxine and human serum albumin (HSA). An HPFA-based online HPLC system was developed to determine the free concentrations of thyroxine enantiomers (L-thyroxine and D-thyroxine).
Both enantiomers exhibited binding to human serum albumin at two high-affinity sites, displaying comparable affinities. According to Scatchard plot analysis, the binding constants (K) and the number of binding sites (n) for l-thyroxine were determined to be K = 1.01 × 10^6 m^-1 and n = 1.90, while for d-thyroxine, K = 9.71 × 10^5 m^-1 and n = 1.97.
The specific binding sites were characterized using phenylbutazone and diazepam as probes for sites I and II, respectively. It was found that each enantiomer can bind to both sites. Additionally, the integration of a chiral HPLC column into the on-line system allowed for the analysis of enantiomer-enantiomer interactions, indicating that they competitively bind to the same sites without exhibiting notable allosteric effects.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.